Piper Sandler Maintains Overweight on Innovex International, Raises Price Target to $34
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Piper Sandler analyst Derek Podhaizer maintains Innovex International (NYSE:INVX) with a Overweight and raises the price target from $33 to $34.
Piper Sandler analyst Derek Podhaizer maintains Innovex International (NYSE:INVX) with a Overweight and raises the price target from $33 to $34.